Around 550 million people have chronic obstructive pulmonary disease (COPD), according to two University of Manchester medical students working with senior researchers supported by Manchester BRC. The figure is more than double the previous estimate by WHO.
Research funded by the NIHR Manchester Biomedical Research Centre (BRC) has led to UK-wide implementation of a novel NHS diagnostic test that uses pyrosequencing (a method of identifying genetic markers in DNA), to identify the right treatment for people with aspergillosis.
Manchester BRC COPD co-lead Professor Dave Singh has received the European Respiratory Society Gold Medal.
In an unprecedented move, scientists and clinicians across Greater Manchester have formed a Rapid Response Research Group to find ways to beat COVID-19 and save lives.
Research funded by NIHR Manchester Biomedical Research Centre (BRC) and the Connected Health Cities Programme has discovered an association between the number of prescriptions for antibiotics and a higher risk of hospital admissions.
Two trials of a new drug have shown that, at low doses, it can ease the often-distressing symptoms of chronic cough with minimal side effects.
In his blog clinical pharmacist, Jake Doherty shares how his six-week NIHR Manchester Biomedical Research Centre (BRC) TRACE-COPD study placement has opened his eyes to new possibilities for a research career.
Professor Paul Dark, Manchester BRC Respiratory Non-fungal Infections Programme Lead and NIHR National Specialty Lead for Critical Care has become an Honorary Fellow of The Royal College of Anaesthetists.